10.28 +0.00 (0.00%)
INCY
Stock Details
Last Trade:10.28 Change:+0.00 (0.00%) Prev Close:10.28 Open: 10.15 Days Range:10.08 – 10.45 52 Week Range: 1.96 - 11.24 Volume:2102388 P/E: N/AEPS:-1.75
View AllRecent Alerts 02/10/10
Recent Alert on 02/05/10 at 11:17am
Monness, Crespi, Hardt Initiates Coverage on Incyte (INCY) with a Buy
Monness, Crespi, Hardt Initiates Coverage on Incyte (INCY) with a Buy
Monness, Crespi, Hardt initiates coverage on Incyte (Nasdaq: INCY) with a Buy rating. To see all the upgrades/downgrades on shares of INCY, visit our Analyst Ratings page. Incyte Corporation (Incyte) is a drug discovery and development company... Read More
Recent Alert on 01/15/10 at 10:55am
Notable Analyst Rating Changes 1/15: AMD, NRG, K, OMX, PRIM Upgraded; TOL, INCY, AYR, CTCM, PAYX Downgraded
Notable Analyst Rating Changes 1/15: AMD, NRG, K, OMX, PRIM Upgraded; TOL, INCY, AYR, CTCM, PAYX Downgraded
View AllRecent Press Releases
Press Release on 02/09/10 at 4:10pm
Incyte to Report 2009 Financial Results and 2010 Financial Guidance and Provide Update on Drug Discovery & Development Programs on February 18
Incyte to Report 2009 Financial Results and 2010 Financial Guidance and Provide Update on Drug Discovery & Development Programs on February 18
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 12/24/09 at 4:01am
Lilly Prepares for Patent Loss in Psychosis Drug, Moves into Arthritis Market
Lilly Prepares for Patent Loss in Psychosis Drug, Moves into Arthritis Market